Possibia

1337258

Last Update Posted: 2017-05-30

Recruiting has ended

Males

accepted

50 Years-75 Years

1 Estimated Participants

No Expanded Access

Observational Study

Does not accept healthy volunteers

Economic Analyses of the REDUCE Trial

The objective of this project is to conduct a retrospective economic analysis of the use of dutasteride for the prevention of prostate cancer based on data from the REDUCE clinical trial. REDUCE is a 4-year, phase 3, randomized, double-blind, parallel assignment clinical trial of the use of dutasteride compared with no chemopreventive treatment.

The REDUCE trial was a four-year, international, multicenter, randomized, double-blind, placebo-controlled, parallel group study. There were 790 investigators in 42 countries.

Eligibility

Relevant conditions:

Neoplasms, Prostate

Benign Prostatic Hyperplasia

Cancer

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov